We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

NST:ASXNorthern Star Resources Ltd Analysis

Data as of 2026-08-26 - not real-time

A$24.45

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Northern Star Resources Limited trades at AUD 24.45, with its moving averages tangled rather than clearly stacked — a neutral trend structure. It has gained 21.7% over the past 30 days. With RSI at 68.4 the momentum picture is approaching overbought, alongside a bullish MACD signal. Recent trading has carved out support near AUD 19.38 and resistance around AUD 24.81.
The shares look fair at 21.1 times earnings, though no sector average was available for comparison. Revenue is growing at 18.7% on a 21.8% profit margin. The 2.24% dividend yield looks covered by current payout levels.
Risk comes out at 8 of a possible 10, a high reading. With 30-day volatility of 40.3%, a beta of 1.22 and a maximum drawdown of 45.8%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 94 on the fear-greed composite.
Across every horizon the signals point the same way: hold, at a conviction of 2 out of 10.

Top Market Events

What is Morgans saying about Northern Star Resources Ltd ASX: NST and Woodside Energy Group Ltd ASX: WDS shares?Xero Ltd ASX: XRO and Northern Star Resources Ltd ASX: NST shares have both lost ground in 2026.What’s happening with S&P/ASX 200 Index ASX: XJO gold stocks Evolution Mining, Newmont Corp, and Northern Star...

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 23.61
  • MACD momentum is positive
  • 30-day price change of +21.7%

Medium Term

1–3 years
Neutral
Model confidence: 2/10

Key Factors

  • Trading above the 200-day average of 23.61
  • 30-day volatility of 40.3%
  • MACD momentum is positive

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • Profit margin of 21.8% is healthy
  • Revenue growth of +18.7%
  • P/E ratio of 21.1

Key Metrics & Analysis

Financial Health

Revenue Growth18.70%
Profit Margin21.83%
P/E Ratio21.1
ROE10.88%
ROA7.32%
Debt/Equity11.00
P/B Ratio2.2
Op. Cash FlowA$3.2B
Free Cash FlowA$385.0M

Technical Analysis

TrendNeutral
RSI68.4
SupportA$19.38
ResistanceA$24.81
MA 20A$22.52
MA 50A$21.18
MA 200A$23.61
MACDBullish
VolumeIncreasing
Fear & Greed Index93.84

Valuation

Fair ValueA$6.93
Target PriceA$23.96
Upside/Downside-2.02%
GradeFair
TypeBlend
Dividend Yield2.24%

Risk Assessment

Beta1.22
Volatility40.28%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.